Loading company…
Riskpilot
← Back to search
Sign in
Get full access
EIRVITAL BIOTECH AS
AS
In liquidation
Org 933223892
Olaf Helsets Vei 5, 0694 Oslo
Wholesale of other food · NACE 4638
Est. 2024
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 0
EBITDA margin
—
-194% vs 2024
Equity ratio
-112.4%
Financial strength
Net profit 2025
NOK -30K
-194% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 0
—
EBITDA
NOK -30K
-194%
Net profit
NOK -30K
-194%
Total assets
NOK 9K
-55%
Equity
NOK -10K
-150%
Employees
—
—
Company information
Legal name
EIRVITAL BIOTECH AS
Org number
933223892
Legal form
Aksjeselskap
NACE code
4638 · Wholesale of other food
Founded
26. mars 2024
Share capital
NOK 30 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Innkjøp og eksport av helserelaterte produkter fra norge til kina.
Contact
Address
Olaf Helsets Vei 5, 0694 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of other food
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
NOK thousands
Item
2024
2025
Revenue
0
0
Staff expenses
−0
−0
EBITDA
−10
−30
Depreciation & amort.
−0
−0
EBIT
−10
−30
Net financials
0
0
Profit before tax
−10
−30
Tax
−0
−0
Net profit
−10
−30
Balance sheet
NOK thousands
Item
2024
2025
Total assets
20
9
Equity
20
−10
Long-term debt
0
19
Short-term debt
0
0
Total debt
0
19
Financial ratios
5-year trend
EBITDA margin
-2981800.0%
This company
15.8%
Market median
-18872252% vs market
2024
2025
Equity ratio
-112.4%
This company
38.2%
Market median
-394% vs market
2024
2025
Return on equity
-2981800.0%
This company
18.4%
Market median
-16205535% vs market
2024
2025
Net profit margin
-2981800.0%
This company
8.1%
Market median
-36812446% vs market
2024
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2025
Debt / equity
1.89×
This company
0.62×
Market median
-205% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
ZL
Zhongjie Li
Chief Executive Officer
Chief Executive Officer
2024
Former (1)
XL
Xhongjie Li
Chief Executive Officer
Chief Executive Officer
2024 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
DN
Dong Ni
Chairman
2024
Former (1)
JH
Jørgen Halstensen Svendgård
Chairman
2024 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of EIRVITAL BIOTECH AS also hold positions in
0
other companies.
Person
Role here
Other companies
Xhongjie Li
Chief Executive Officer
0 companies
Zhongjie Li
Chief Executive Officer
0 companies
Jørgen Halstensen Svendgård
Chairman
0 companies
Dong Ni
Chairman
0 companies